Publication | Closed Access

Consolidation anti-CD22 fractionated radioimmunotherapy with 90 Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial

Lymphoid NeoplasiaAutoimmune DiseaseConsolidation Anti-cd22Elderly PatientsMedicineImmunologyAutoimmunityPhase 2ImmunotherapyOncologyRadiation OncologyAdult T-cell Leukemia-lymphoma